Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ZBIO Zenas BioPharma, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $27.94 +3.6% | $15.90 -2.5% |
| StockIQ Score | 43D Weak Risk: Medium | 41D Weak Risk: High |
| Technical | 36F | 36F |
| Fundamental | 34F | 35F |
| Growth | 54C- | 50C- |
| Fair Value | 38F | 38F |
| News | 68B- | 50C- |
| Quality | 47D+ | 50C- |
| Risk | 46D+ | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Zenas BioPharma (ZBIO) has a slightly stronger growth score (54 vs. 50) compared to Ascentage Pharma (AAPG), indicating better perceived growth potential. Both stocks share identical technical (36) and valuation (38) scores, while ZBIO’s fundamental score (34) is marginally lower than AAPG’s (35). Investor scores are close, with AAPG slightly ahead at 41 versus ZBIO’s 43. Neither stands out in any category.
